Menu

Prescribing guidelines

Loading…

Clinical support by body system

Conditions and indicators

Alcohol dependence1
Allergic rhinitis1
Angina pectoris1
Antiplatelets1
Asthma2
Atrial fibrillation1
Cancer : Palliative care1
Depression2
Dysphagia1
Epilepsy3
Heart failure4
Incontinence2
Inflammatory Bowel Disease1
Neuropathic pain1
Obesity and bariatric surgery1
Osteoporosis2
Pain management6
Peptic ulcers1
Rheumatoid arthritis1
Stroke2
Substance dependence1
Transient Ischaemic Attack TIA1
Type 1 Diabetes2
Type 2 Diabetes2

Traffic light

April 2022 - APC Approved list of guideline review date extensions (to 3 years from date approved)

MSK: Vitamin D guidelines - Adult (APC Approved)

Cancer, Palliative Care, Pain and Older People Dermatology, MSK and Rheumatology Gastroenterology Laboratory investigations and Infections
MSK: Vitamin D Guidelines - Children (APC Approved)

Dermatology, MSK and Rheumatology Paediatrics
Neuro: South Yorkshire Rimegepant (Vydura®) Supporting Information for Acute Treatment of Migraine in Adults (IMOC approved)
Neuro: South Yorkshire Rimegepant for Treating a Migraine Attack Patient Information (IMOC approved)
Neuro: South Yorkshire Valproate Guidance in Primary Care (APC Approved)
Neuro: Topiramate Guidance: Assessing female patients of childbearing potential in primary care
Paed: Health Visitor Formulary (APC Approved)

Paediatrics
Paed/Derm: Infant Seborrhoeic Dermatitis (Cradle Cap) Position Statement
Paeds: NPPG Position Statement - Using Standardised Concentrations of Liquid Medicines in Children (APC Approved)

Paediatrics
Pain: Buprenorphine (APC approved)

Cancer, Palliative Care, Pain and Older People Dermatology, MSK and Rheumatology

Did you find this page helpful?